Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development Sep 30 • 5 min read Field Trip Psychedelics Inc. have completed GLP (Good Laboratory Practices) synthesis of its first molecule in development, FT-104.
Better Plant Sciences Subsidiary NeonMind Signs Psilocybin Supply Agreement for Clinical Trials Sep 29 • 8 min read Better Plant Sciences Inc. announced that NeonMind Biosciences has entered into an agreement with Psygen Labs Inc. for the supply of psilocybin for NeonMind’s planned trials.
Red Light Holland Reaches Distribution Agreement for iMicrodose Packs Plus Agrees to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart’s Location in Tiel, The Netherlands Sep 28 • 5 min read Red Light Holland Corp. have announced their iMicrodose Packs.
MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin Sep 25 • 4 min read Mind Medicine (MindMed) Inc. announced that they have been conducting R&D work on psilocybin in collaboration with the University Hospital Basel’s Liechti Lab.
Havn Life Sciences submits range of natural health products to Health Canada Sep 24 • 2 min read Havn Life Sciences Inc. announced that it has submitted formulations for its natural health products to Health Canada.